Kerecis Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- Kerecis's estimated annual revenue is currently $26.4M per year.
- Kerecis's estimated revenue per employee is $251,000
- Kerecis has 105 Employees.
- Kerecis grew their employee count by 17% last year.
- Kerecis currently has 5 job openings.
What Is Kerecis?
Kerecis has developed the unique, patented Kerecisâ„¢ Omega3 fish-skin transplantation technology, where intact fish skin is used for tissue regeneration. The Kerecisâ„¢ Omega3 transplantation technology is used to reconstruct tissue damage such as burn and diabetic wounds as well as for oral wounds, hernia repair, breast reconstruction and for dura restoration. Other tissue-transplant products are based on tissues of human and porcine origin. The Kerecisâ„¢ Omega3 fish skin offers improved economics and clinical performance, as well as reduced disease transfer risk and no cultural constraints on usage. Kerecisâ€™ second technology platform is the patented mOmega3 polyunsaturated fatty acid technology, where fatty acids are extracted from fish skin and incorporated in patented dermatological skin treatment products.keywords:Biotechnology, Medical Devices